Reid Huber, PhD - 2021 World Medical Innovation Forum
May 2–4, 2022
Reid Huber
This speaker appears at this event:

This speaker appears in these events:

Reid Huber, PhD

Partner, Third Rock Ventures

Reid Huber joined Third Rock in 2018, bringing 20 years of leadership and experience to the role. He focuses on the formation, development and strategy of our portfolio companies, and was involved in the launch of MOMA Therapeutics, serving as interim CEO. He also serves as a member of the Board of Directors at Tango Therapeutics.
Reid joined the firm from Incyte, where he was a member of the founding scientific team and most recently served as executive vice president and chief scientific officer. At Incyte, he held roles of increasing responsibility across multiple therapeutic areas in both drug discovery and clinical development. In 2011, he assumed responsibility for the company’s research activities as Senior Vice President, Discovery Biology. Before joining Incyte, Reid held scientific research positions at DuPont and Bristol-Myers Squibb from 1998 to 2002. He received his Ph.D. in molecular genetics from the Washington University School of Medicine and held predoctoral and postdoctoral fellowships at the National Institutes of Health.

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA